Drawing conclusions from the VIVA trial

Lancet. 2018 May 12;391(10133):1894. doi: 10.1016/S0140-6736(18)30786-4. Epub 2018 May 10.

Authors

Karsten Juhl Jørgensen¹, Minna Johansson²

Affiliations

¹ The Nordic Cochrane Centre, Rigshospitalet Department 7811, 2100 Copenhagen, Denmark. Electronic address: kj@cochrane.dk.
² Department of Public Health and Community Medicine, Institute of Medicine, University of Gothenburg, Gothenburg, Sweden.

PMID: 29781439
DOI: 10.1016/S0140-6736(18)30786-4

No abstract available

Publication types

Letter
Comment

MeSH terms

Humans
Male
Randomized Controlled Trials as Topic
Vascular Diseases* / diagnosis
Vascular Diseases* / therapy